Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors

Eitemau Tebyg

• Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
  gan: Marfatia, Yogesh S., et al.
  Cyhoeddwyd: (2014)
• In Vitro Mitochondrial Toxicity of Metacavir, a New Nucleoside Reverse Transcriptase Inhibitor for Treatment of Hepatitis B Virus
  gan: Zhang, Pinghu, et al.
  Cyhoeddwyd: (2010)
• Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
  gan: Gwag, Taesik, et al.
  Cyhoeddwyd: (2019)
• Tempol Protects Cardiomyocytes from Nucleoside Reverse Transcriptase Inhibitor-Induced Mitochondrial Toxicity
  gan: Liu, Yongmin, et al.
  Cyhoeddwyd: (2014)
• Abstracts from the current global literature: Mitochondrial toxicities due to nucleoside reverse transcriptase inhibitors
  gan: Jain, Sonia, et al.
  Cyhoeddwyd: (2012)